MTX-463

BIOLOGICAL3 trials

Sponsors

Mediar Therapeutics

Conditions

HealthyHealthy Adult MaleIdiopathic Pulmonary Fibrosis

Phase 1

A First-in-Human Safety Trial of MTX-463

CompletedNCT06401213

Mediar TherapeuticsHealthy

Start: 2024-04-15End: 2024-11-15Updated: 2025-01-17

Evaluation of MTX-463 Administered Subcutaneously in Healthy Adult Males

CompletedNCT07450521

Mediar TherapeuticsHealthy Adult Male

Start: 2026-02-18End: 2026-03-11Updated: 2026-03-30

Phase 2

WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

RecruitingNCT06967805

Mediar TherapeuticsIdiopathic Pulmonary Fibrosis

Start: 2025-05-05End: 2027-08-01Target: 164Updated: 2026-08-10